when 44 year-old Brian Madeux received the experimental therapy to correct a DNA defect causing Hunter’s syndrome. Madeux, from Arizona, volunteered to undergo the trial of Sangamo Therapeutic's ...

The groundbreaking trial hit the headlines around the world in November when Brian Madeux volunteered to be the first human to try out the ‘in vivo’ therapy. He has Hunter syndrome ...